Indegene Limited (BOM:544172)

Market Cap	129.46B
Revenue (ttm)	30.39B
Net Income (ttm)	4.46B
Shares Out	n/a
EPS (ttm)	18.50
PE Ratio	29.04
Forward PE	25.94
Dividend	2.00 (0.37%)
Ex-Dividend Date	Jun 13, 2025

Volume	45,304
Average Volume	14,566
Open	555.10
Previous Close	552.40
Day's Range	534.00 - 555.15
52-Week Range	485.15 - 735.00
Beta	n/a
RSI	42.72
Earnings Date	Oct 30, 2025

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Commercial Physical and Biological Research
• Founded: 1998
• Employees: 4,158
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544172

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.